Learn more

INST BIOCHEMII I BIOFIZYKI POLSKIEJ AKADEMII NAUK

Overview
  • Total Patents
    89
  • GoodIP Patent Rank
    25,554
  • Filing trend
    ⇩ 60.0%
About

INST BIOCHEMII I BIOFIZYKI POLSKIEJ AKADEMII NAUK has a total of 89 patent applications. It decreased the IP activity by 60.0%. Its first patent ever was published in 2010. It filed its patents most often in Poland, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and macromolecular chemistry and polymers are TARGOVAX ASA, UNIV HEIDELBERG RUPRECHT KARLS and CANADIAN BLOOD SERVICES.

Patent filings per year

Chart showing INST BIOCHEMII I BIOFIZYKI POLSKIEJ AKADEMII NAUKs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Gozdek Agnieszka 18
#2 Górski Andrzej 15
#3 Bal Wojciech 12
#4 Zawisza Izabela 12
#5 Gromadka Robert 11
#6 Łobocka Małgorzata 11
#7 Gawor Jan 10
#8 Izak Dariusz 10
#9 Sirko Agnieszka 10
#10 Zielenkiewicz Piotr 9

Latest patents

Publication Filing date Title
PL426477A1 Bacterial starter culture for spelt bread, a sourdough containing it, method of producing bread and application of bacterial starter culture or a sourdough for bread production
PL423299A1 Method for cleanup of the environment contaminated by sulfur esters, new bacterial strains, new proteins, nucleic acid construct, vector, host cell, method for producing bacterial strains and new proteins, a composition of their application and method for the environment bioremediation
PL422982A1 Universal antigen, universal vaccine against influenza, the system for production of the vaccine, method of production of the antigen and application of the antigen for production of the universal vaccine against influenza
PL434475A1 Bacterial starter culture, leaven containing it, method for producing bakery products and application of the bacterial starter culture of the leaven for production of the bakery products
PL422852A1 Bacterial starter culture, leaven containing it, method for producing bakery products and application of the bacterial starter culture of the leaven for production of the bakery products
PL434470A1 Bacterial starter culture, leaven containing it, method for producing bakery products and application of the bacterial starter culture of the leaven for production of the bakery products
PL419848A1 Proteins from ALKBH group to be applied in the method of diagnosing tumour diseases, their application for identification of substances with antitumour properties, and derivatives of anthraquinone to be used as the anticancer drug in the tumour disease treatment and/or preventing method
PL415033A1 Method for analysis of proteins in urine
PL415013A1 Composition of micro-organism grafts and method for utilization of sewage waste
PL414159A1 Multiplex cytokeratin panel, method for producing the multiplex cytokeratin panel and method for classifying patients with lung neoplasm
PL413560A1 Application of oligonucleotide molecule for modulation of inflammatory processes and/or processes depending on FAN protein
PL413392A1 Transgenic plant with increased tolerance to stress, method for obtaining the plant with increased tolerance to stress and application of the gene or its homologue to increase the plant tolerance to stress
PL413262A1 Monoclonal mouse antibody, recombinant fusion protein, application of antibodies, immunosensor for detection influenza virus and method for producing the immunosensor
PL411543A1 An agent increasing effectiveness of DNA vaccine directed against a virus, DNA plasmid preparation, DNA vaccine, method for obtaining modified expressive vector and the application of nucleotide sequence recognized by the agent NF kappa B.
US2017056508A1 Method for synthesis of a biopolymer derivative, a biopolymer derivative and its use
PL411230A1 DNA vaccine directed against the flue H5N1 virus, modified nucleotide sequence and application of the modified nucleotide sequence for production of the vaccine
PL410063A1 Vaccine, pharmaceutical composition, carrier of nucleic acids and other biologically active substances, application of the composition in production of the vaccine and application of cationic derivatives of polyprenols PTAI for producing immunomodulating substances
PL409330A1 Staphylococcus aureus strains for the production of monoclonal phage preparations deprived of impurities by plasmid DNA
PL434249A1 Enterococcus faecalis strain for the production of monoclonal phage preparations
PL434248A1 Staphylococcus aureus strain for the production of monoclonal phage preparations deprived of impurities by plasmid DNA